NK Cell Therapy Market Landscape: Opportunities and Challenges (2034)
Natural Killer (NK) cell therapy represents a revolutionary advancement in the field of immunotherapy. NK cells are a type of cytotoxic lymphocyte critical to the innate immune system, offering a unique mechanism for targeting and eliminating cancerous and infected cells. Unlike other immunotherapies, NK cell-based treatments are not reliant on genetic modifications, reducing production complexities and costs. With growing interest in this promising therapeutic approach, the NK cell therapy market is poised for significant expansion. NK Cell Therapy Market Insights The NK cell therapy therapeutics market is driven by its broad therapeutic potential, ranging from hematological malignancies and solid tumors to infectious diseases and autoimmune disorders. Several therapies are advancing through clinical trials, including oNKord by Glycostem, FT522 by Fate Therapeutics, and AlloNK (AB-101) . These therapies are designed to target specific cancer types or enhance the efficacy of mo...